Exclusive Interview: LianBio and Pfizer Create a First-in-Kind Collaboration in Greater China
November 18, 2020 at 23:15 PM EST
Today, LianBio, a Princeton-Shanghai company, and Pfizer announced an innovative agreement to co-develop and co-commercialize novel pharmaceuticals in Greater China. "We started talking to Pfizer several months ago," said Adam Stone, Chief Investment Officer of Perceptive Advisors, LianBio's parent, in an exclusive interview with ChinaBio® Today . "We didn't have a final structure in mind. We just asked the question, 'How can these two platforms work together in a mutually beneficial way?'" More details.... Stock Symbol: (NYSE: PFE) Share this with colleagues: // //